Melissa Lapierre-Devlin, based in Boston, MA, US, is currently a Executive Director at Aruvant, bringing experience from previous roles at Sarepta Therapeutics, Takeda Pharmaceuticals and Takeda Oncology. Melissa Lapierre-Devlin holds a 2006 - 2009 Master of Business Administration @ University Of Massachusetts - Amherst. With a robust skill set that includes Assay Development, HPLC, Cell Culture, Immunoassays, Purification and more, Melissa Lapierre-Devlin contributes valuable insights to the industry. Melissa Lapierre-Devlin has 1 email on RocketReach.